PROMINENCE BIO-CHEM RESEARCH & DEVELOPMENT CO., LIMITED

Yes. PROMINENCE BIO-CHEM RESEARCH & DEVELOPMENT CO., LIMITED is a legitimate Hong Kong corporation (Private company limited by shares) duly incorporated under the Companies Ordinance (Cap. 622) on statutory historical records (operating for under 1 year (Newly Incorporated)). According to official registers of the Hong Kong Companies Registry (CR), the entity holds an active statutory standing of [Live / In Operation], possessing independent legal personality and full corporate capacity (Statutory verification: September 2026).

The statutory primary identifiers for PROMINENCE BIO-CHEM RESEARCH & DEVELOPMENT CO., LIMITED are: 1. Business Registration Number (BRN / Unique Business Identifier UBI): [64443725] (effective from 27 December 2023, this 8-digit number issued under Cap. 310 serves as the unified cross-departmental corporate identifier); 2. Company Registration Number (CRN): [2206271] (incorporation archive number issued under Cap. 622). Together, these dual keys uniquely lock the entity in international banking KYC and cross-border contracts.

Under the Companies Ordinance (Cap. 622), Hong Kong corporations do not have a 'legal representative' role; executive authority vests in the Board of Directors (Section 643). Because PROMINENCE BIO-CHEM RESEARCH & DEVELOPMENT CO., LIMITED was incorporated within the past year (statutory historical records) and its first Annual Return (Form NAR1) is not yet due, its founding directors, company secretary, and initial share capital allotment are officially recorded in its Incorporation Form (Form NNC1), supplemented by any subsequent Return of Allotment (Form NSC1) or Notice of Change of Director (Form ND2A).

Pursuant to the Companies Ordinance (Cap. 622), statutory filings delivered by PROMINENCE BIO-CHEM RESEARCH & DEVELOPMENT CO., LIMITED—such as Incorporation Forms (Form NNC1), Annual Returns (Form NAR1 under Section 662), and notices of director or registered office changes (Form ND2A / Form NR1)—are maintained by the Hong Kong Companies Registry. Where online electronic image indexing is pending synchronization or involves early historical microfiche archives, manual statutory retrieval from the Companies Registry can be commissioned through our compliance team.

According to multi-dimensional checks across Hong Kong statutory authorities: 1. Regulatory Licences: Cross-referenced across Hong Kong statutory regulatory registers (including HKMA, SFC, Companies Registry TCSP, Customs MSO/DPMS, and Insurance Authority IA), this entity holds no special statutory financial licence, operating as a general commercial corporation; 2. Judicial Screening (Litigation & Winding-Up): cross-referenced with the Hong Kong Judiciary public writs database and Official Receiver's Office (ORO) registers; no public civil action writs (HCA/DCCJ) or compulsory winding-up petitions (HCCW under Cap. 32) were found on current index records.

Under Section 127 of the Companies Ordinance (Cap. 622), Hong Kong has abolished the mandatory use of a metallic common seal; PROMINENCE BIO-CHEM RESEARCH & DEVELOPMENT CO., LIMITED (CRN: 2206271 / 8-digit BRN: 64443725) may lawfully execute a commercial contract without a common seal by having the document signed on its behalf by its sole director (for a single-director company) or by two directors / one director and the company secretary, and under Cap. 622B Section 4 must state its registered legal name on all contracts, transaction instruments, and official websites. Because commercial rubber chops are not registered with the Hong Kong Government, counterparties must retrieve the latest Annual Return (Form NAR1), director change notices (Form ND2A), and Register of Charges filings (Form NM1 under Cap. 622 s.334) from the Companies Registry to verify authorized signatory directors and asset pledges.